Due to the absence of differences in copeptin concentration in asphyxiated infants (AKI group and no-AKI) and healthy children, we suggest that copeptin cannot be a valuable, early marker of asphyxia and AKI in neonates. The gene discussed is AVP; the disease is acute kidney injury.